$2.85 Billion is the total value of Tekla Capital Management LLC's 175 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 14.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UNH | Buy | Unitedhealth Group Inc. | $168,303,000 | +4.6% | 330,026 | +3.0% | 5.91% | +14.2% |
| AMGN | Amgen Inc. | $139,027,000 | +7.5% | 574,918 | 0.0% | 4.88% | +17.3% | |
| REGN | Buy | Regeneron Pharmaceuticals, Inc. | $102,109,000 | +13.0% | 146,200 | +2.2% | 3.59% | +23.4% |
| HZNP | Buy | Horizon Therapeutics plcshares | $100,943,000 | +4.4% | 959,439 | +6.9% | 3.54% | +13.9% |
| GILD | Gilead Sciences, Inc. | $100,266,000 | -18.1% | 1,686,565 | 0.0% | 3.52% | -10.6% | |
| JNJ | Johnson & Johnson | $91,566,000 | +3.6% | 516,652 | 0.0% | 3.22% | +13.1% | |
| ABBV | Buy | AbbVie Inc. | $88,860,000 | +28.7% | 548,144 | +7.5% | 3.12% | +40.5% |
| VRTX | Buy | Vertex Pharmaceuticals Inc. | $80,609,000 | +34.4% | 308,884 | +13.1% | 2.83% | +46.8% |
| ILMN | Illumina, Inc. | $79,038,000 | -8.2% | 226,212 | 0.0% | 2.78% | +0.3% | |
| ABT | Buy | Abbott Laboratories | $73,238,000 | -10.8% | 618,777 | +6.1% | 2.57% | -2.6% |
| AZN | Buy | AstraZeneca PLCsponsored adr | $65,721,000 | +43.3% | 990,675 | +25.8% | 2.31% | +56.4% |
| MCK | Buy | McKesson Corp. | $63,070,000 | +34.6% | 206,022 | +9.3% | 2.22% | +46.9% |
| PFE | Pfizer Inc. | $60,669,000 | -12.3% | 1,171,903 | 0.0% | 2.13% | -4.3% | |
| LLY | Sell | Eli Lilly and Company | $60,662,000 | -4.7% | 211,832 | -8.1% | 2.13% | +4.0% |
| SYK | Buy | Stryker Corp. | $60,335,000 | +22.9% | 225,678 | +22.9% | 2.12% | +34.1% |
| TMO | Sell | Thermo Fisher Scientific Inc. | $57,650,000 | -43.3% | 97,605 | -35.9% | 2.02% | -38.1% |
| MRNA | Sell | Moderna, Inc. | $56,592,000 | -59.2% | 328,524 | -39.9% | 1.99% | -55.5% |
| BMY | Sell | Bristol-Myers Squibb Company | $52,865,000 | +13.5% | 723,876 | -3.1% | 1.86% | +23.9% |
| MDT | Sell | Medtronic plcshares | $48,279,000 | -7.7% | 435,140 | -14.0% | 1.70% | +0.7% |
| SGEN | Sell | Seagen Inc. | $47,617,000 | -22.9% | 330,561 | -17.3% | 1.67% | -15.9% |
| MRK | Sell | Merck & Co., Inc. | $47,230,000 | -21.8% | 575,622 | -27.0% | 1.66% | -14.7% |
| DHR | Sell | Danaher Corp. | $44,042,000 | -33.8% | 150,145 | -25.8% | 1.55% | -27.8% |
| CI | Buy | Cigna Corp. | $41,218,000 | +25.2% | 172,023 | +19.9% | 1.45% | +36.6% |
| IDXX | Sell | IDEXX Laboratories, Inc. | $33,489,000 | -36.2% | 61,217 | -23.2% | 1.18% | -30.3% |
| MOH | Sell | Molina Healthcare, Inc. | $31,533,000 | +0.8% | 94,525 | -3.9% | 1.11% | +10.0% |
| HCA | Buy | HCA Healthcare, Inc. | $31,153,000 | +8.3% | 124,303 | +11.0% | 1.09% | +18.1% |
| SYNH | Sell | Syneos Health, Inc.class a | $30,888,000 | -25.4% | 381,570 | -5.3% | 1.08% | -18.5% |
| BIIB | Biogen Inc. | $28,566,000 | -12.2% | 135,639 | 0.0% | 1.00% | -4.2% | |
| HUM | Sell | Humana Inc. | $27,659,000 | -14.4% | 63,560 | -8.8% | 0.97% | -6.6% |
| ZTS | Buy | Zoetis Inc.class a | $26,623,000 | -10.9% | 141,167 | +15.2% | 0.94% | -2.8% |
| ALNY | Sell | Alnylam Pharmaceuticals, Inc. | $25,899,000 | -19.5% | 158,606 | -16.4% | 0.91% | -12.1% |
| BSX | Buy | Boston Scientific Corp. | $25,219,000 | +10.8% | 569,398 | +6.2% | 0.89% | +20.9% |
| GH | Guardant Health, Inc. | $23,282,000 | -33.8% | 351,484 | 0.0% | 0.82% | -27.7% | |
| IQV | IQVIA Holdings Inc. | $22,694,000 | -18.1% | 98,154 | 0.0% | 0.80% | -10.5% | |
| JAZZ | Buy | Jazz Pharmaceuticals plcshares | $21,867,000 | +46.3% | 140,473 | +19.7% | 0.77% | +59.7% |
| ICLR | Sell | Icon plcshares | $21,461,000 | -29.9% | 88,237 | -10.8% | 0.75% | -23.5% |
| EW | Edwards Lifesciences Corp. | $20,859,000 | -9.1% | 177,188 | 0.0% | 0.73% | -0.8% | |
| BDX | Buy | Becton, Dickinson and Company | $19,665,000 | +80.6% | 73,930 | +70.7% | 0.69% | +97.4% |
| WELL | Welltower Inc. | $19,524,000 | +12.1% | 203,083 | 0.0% | 0.69% | +22.5% | |
| DXCM | Sell | Dexcom, Inc. | $18,761,000 | -16.7% | 36,671 | -12.5% | 0.66% | -9.0% |
| ZBH | Zimmer Biomet Holdings, Inc. | $18,167,000 | +0.7% | 142,044 | 0.0% | 0.64% | +9.8% | |
| SRPT | Sell | Sarepta Therapeutics, Inc. | $17,788,000 | -37.5% | 227,697 | -27.9% | 0.62% | -31.7% |
| ITCI | Buy | Intra-Cellular Therapies, Inc. | $17,802,000 | +43.8% | 290,936 | +23.0% | 0.62% | +57.0% |
| CRL | Charles River Laboratories International, Inc. | $17,603,000 | -24.6% | 61,990 | 0.0% | 0.62% | -17.8% | |
| ISRG | Intuitive Surgical, Inc. | $17,379,000 | -16.0% | 57,606 | 0.0% | 0.61% | -8.4% | |
| RMD | Sell | ResMed Inc. | $17,218,000 | -11.4% | 70,999 | -4.8% | 0.60% | -3.2% |
| NVO | Buy | Novo Nordisk A/Ssponsored adr | $17,049,000 | +28.6% | 153,523 | +29.7% | 0.60% | +40.3% |
| BNTX | Buy | BioNTech SEsponsored ads | $16,210,000 | -30.3% | 95,042 | +5.3% | 0.57% | -24.0% |
| XLV | Health Care Select Sector SPDR Fundsbi healthcare | $15,511,000 | -2.8% | 113,230 | 0.0% | 0.54% | +6.2% | |
| Sell | Rallybio Corp. | $15,321,000 | -24.9% | 2,195,010 | -4.9% | 0.54% | -18.1% | |
| VTR | Ventas, Inc. | $15,325,000 | +20.8% | 248,131 | 0.0% | 0.54% | +31.9% | |
| CVS | CVS Health Corp. | $14,924,000 | -1.9% | 147,453 | 0.0% | 0.52% | +7.2% | |
| UTHR | Sell | United Therapeutics Corp. | $12,954,000 | -41.1% | 72,206 | -29.0% | 0.46% | -35.6% |
| KRTX | Karuna Therapeutics, Inc. | $12,737,000 | -3.2% | 100,458 | 0.0% | 0.45% | +5.7% | |
| OMI | Owens & Minor, Inc. | $12,685,000 | +1.2% | 288,167 | 0.0% | 0.44% | +10.4% | |
| ARGX | argenx SEsponsored adr | $12,126,000 | -10.0% | 38,456 | 0.0% | 0.43% | -1.6% | |
| NVS | Novartis AGsponsored adr | $11,954,000 | +0.3% | 136,225 | 0.0% | 0.42% | +9.7% | |
| NBIX | Neurocrine Biosciences, Inc. | $11,682,000 | +10.1% | 124,609 | 0.0% | 0.41% | +20.2% | |
| LH | Laboratory Corporation of America Holdingssponsored adr | $11,638,000 | -16.1% | 44,142 | 0.0% | 0.41% | -8.3% | |
| RARE | Ultragenyx Pharmaceutical Inc. | $10,220,000 | -13.6% | 140,726 | 0.0% | 0.36% | -5.8% | |
| APLS | Apellis Pharmaceuticals, Inc. | $9,950,000 | +7.5% | 195,820 | 0.0% | 0.35% | +17.1% | |
| BMRN | BioMarin Pharmaceutical Inc. | $9,869,000 | -12.7% | 128,004 | 0.0% | 0.35% | -4.7% | |
| BGNE | Sell | BeiGene, Ltd.sponsored adr | $9,622,000 | -44.3% | 51,018 | -20.0% | 0.34% | -39.2% |
| OHI | Omega Healthcare Investors, Inc. | $9,548,000 | +5.3% | 306,433 | 0.0% | 0.34% | +14.7% | |
| QURE | uniQure N.V.shares | $9,427,000 | -12.9% | 521,693 | 0.0% | 0.33% | -4.9% | |
| A | Buy | Agilent Technologies, Inc. | $8,846,000 | +39.8% | 66,845 | +68.7% | 0.31% | +52.5% |
| WAT | Waters Corp. | $8,834,000 | -16.7% | 28,461 | 0.0% | 0.31% | -9.1% | |
| MPW | Medical Properties Trust, Inc. | $8,704,000 | -10.5% | 411,743 | 0.0% | 0.31% | -2.2% | |
| DOC | Physicians Realty Trust | $8,695,000 | -6.9% | 495,733 | 0.0% | 0.30% | +1.7% | |
| XBI | New | SPDR S&P Biotech ETFs&p biotech etf | $8,597,000 | – | 95,649 | +100.0% | 0.30% | – |
| BHVN | Biohaven Pharmaceutical Holding Company Ltd. | $8,321,000 | -14.0% | 70,176 | 0.0% | 0.29% | -6.1% | |
| ALGN | Buy | Align Technology, Inc. | $8,238,000 | +68.1% | 18,894 | +153.3% | 0.29% | +82.9% |
| ASND | Ascendis Pharma A/Ssponsored adr | $7,956,000 | -12.8% | 67,794 | 0.0% | 0.28% | -4.8% | |
| ADUS | Addus HomeCare Corp. | $7,802,000 | -0.2% | 83,632 | 0.0% | 0.27% | +8.7% | |
| SBRA | Sabra Health Care REIT, Inc. | $7,604,000 | +10.0% | 510,660 | 0.0% | 0.27% | +20.3% | |
| ANTM | Anthem, Inc. | $7,193,000 | +6.0% | 14,644 | 0.0% | 0.25% | +16.1% | |
| DNLI | Denali Therapeutics Inc. | $7,155,000 | -27.9% | 222,420 | 0.0% | 0.25% | -21.3% | |
| LTC | LTC Properties, Inc. | $7,013,000 | +12.7% | 182,293 | 0.0% | 0.25% | +23.0% | |
| HQY | New | HealthEquity, Inc. | $6,967,000 | – | 103,314 | +100.0% | 0.24% | – |
| MRTX | Mirati Therapeutics, Inc. | $6,889,000 | -43.9% | 83,784 | 0.0% | 0.24% | -38.7% | |
| IONS | Ionis Pharmaceuticals, Inc. | $6,507,000 | +21.7% | 175,680 | 0.0% | 0.23% | +33.1% | |
| Caribou Biosciences, Inc. | $6,420,000 | -35.0% | 699,377 | 0.0% | 0.22% | -29.2% | ||
| AMN | AMN Healthcare Services, Inc. | $6,385,000 | -14.7% | 61,201 | 0.0% | 0.22% | -7.1% | |
| TVTX | Buy | Travere Therapeutics, Inc. | $6,383,000 | -3.4% | 247,678 | +16.4% | 0.22% | +5.2% |
| SNY | Sanofisponsored adr | $6,338,000 | +2.5% | 123,454 | 0.0% | 0.22% | +12.1% | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $6,200,000 | -30.6% | 134,812 | 0.0% | 0.22% | -24.3% | |
| BPMC | New | Blueprint Medicines Corp. | $6,213,000 | – | 97,253 | +100.0% | 0.22% | – |
| PKI | PerkinElmer, Inc. | $5,835,000 | -13.2% | 33,444 | 0.0% | 0.20% | -5.1% | |
| SNN | Smith & Nephew plcsponsored adr | $5,797,000 | -7.9% | 181,710 | 0.0% | 0.20% | +1.0% | |
| ARVN | Arvinas, Inc. | $5,788,000 | -18.1% | 85,997 | 0.0% | 0.20% | -10.6% | |
| RCM | R1 RCM Inc. | $5,415,000 | +5.0% | 202,351 | 0.0% | 0.19% | +14.5% | |
| QGEN | Qiagen N.V.shares | $5,285,000 | -11.8% | 107,855 | 0.0% | 0.19% | -3.6% | |
| PEAK | Healthpeak Properties, Inc. | $5,163,000 | -4.9% | 150,392 | 0.0% | 0.18% | +3.4% | |
| PHG | Koninklijke Philips N.V.ny reg shares | $5,031,000 | -17.2% | 164,790 | 0.0% | 0.18% | -9.2% | |
| ALKS | Sell | Alkermes plcshares | $5,002,000 | -22.4% | 190,122 | -31.4% | 0.18% | -15.4% |
| ACHC | New | Acadia Healthcare Company, Inc. | $4,738,000 | – | 72,307 | +100.0% | 0.17% | – |
| NVAX | Novavax, Inc. | $4,699,000 | -48.5% | 63,800 | 0.0% | 0.16% | -43.9% | |
| ADPT | Adaptive Biotechnologies Corp. | $4,688,000 | -50.5% | 337,722 | 0.0% | 0.16% | -45.9% | |
| CYTK | Buy | Cytokinetics, Inc. | $4,413,000 | +4.3% | 119,898 | +29.1% | 0.16% | +14.0% |
| TEVA | Teva Pharmaceutical Industries Ltd.sponsored adr | $4,316,000 | +17.2% | 459,651 | 0.0% | 0.15% | +28.8% | |
| NTLA | Intellia Therapeutics, Inc. | $4,228,000 | -38.5% | 58,180 | 0.0% | 0.15% | -33.0% | |
| STE | STERIS plcshares | $4,030,000 | -0.7% | 16,669 | 0.0% | 0.14% | +8.4% | |
| VRNA | Verona Pharma plcsponsored adr | $3,752,000 | -25.7% | 751,905 | 0.0% | 0.13% | -19.0% | |
| VECT | VectivBio Holding AGordinary shares | $3,556,000 | -4.3% | 756,502 | 0.0% | 0.12% | +4.2% | |
| CRSP | CRISPR Therapeutics AGnamen akt | $3,457,000 | -17.2% | 55,080 | 0.0% | 0.12% | -9.7% | |
| GTHX | G1 Therapeutics, Inc. | $3,221,000 | -25.6% | 423,869 | 0.0% | 0.11% | -18.7% | |
| BCRX | New | BioCryst Pharmaceuticals, Inc. | $3,197,000 | – | 196,625 | +100.0% | 0.11% | – |
| XNCR | New | Xencor, Inc. | $3,006,000 | – | 112,673 | +100.0% | 0.11% | – |
| TAK | Takeda Pharmaceutical Company Ltd.sponsored ads | $3,009,000 | +5.1% | 210,146 | 0.0% | 0.11% | +15.2% | |
| PTGX | Buy | Protagonist Therapeutics, Inc. | $2,895,000 | -16.2% | 122,271 | +21.0% | 0.10% | -8.1% |
| HR | Healthcare Realty Trust Inc. | $2,859,000 | -13.1% | 104,024 | 0.0% | 0.10% | -5.7% | |
| GMRE | Global Medical REIT Inc. | $2,854,000 | -8.1% | 174,897 | 0.0% | 0.10% | 0.0% | |
| XRAY | DENTSPLY SIRONA Inc. | $2,825,000 | -11.8% | 57,400 | 0.0% | 0.10% | -3.9% | |
| HLXA | Helix Acquisition Corp.class a | $2,775,000 | +12.2% | 250,000 | 0.0% | 0.10% | +21.2% | |
| IMAB | I-Mabsponsored ads | $2,640,000 | -65.7% | 162,580 | 0.0% | 0.09% | -62.5% | |
| Buy | Pyxis Oncology, Inc. | $2,630,000 | +77.6% | 708,303 | +424.7% | 0.09% | +91.7% | |
| CERE | Buy | Cerevel Therapeutics Holdings, Inc. | $2,580,000 | +94.1% | 73,681 | +79.7% | 0.09% | +111.6% |
| AFMD | Affimed N.V. | $2,561,000 | -20.8% | 586,038 | 0.0% | 0.09% | -13.5% | |
| ARQT | Arcutis Biotherapeutics, Inc. | $2,535,000 | -7.1% | 131,633 | 0.0% | 0.09% | +1.1% | |
| MRUS | Buy | Merus N.V. | $2,519,000 | +89.3% | 95,290 | +127.7% | 0.09% | +104.7% |
| HTA | Healthcare Trust of America, Inc. | $2,215,000 | -6.1% | 70,662 | 0.0% | 0.08% | +2.6% | |
| HOLX | Hologic, Inc. | $2,178,000 | +0.4% | 28,347 | 0.0% | 0.08% | +8.6% | |
| GRTX | Galera Therapeutics, Inc. | $2,138,000 | -48.2% | 898,374 | 0.0% | 0.08% | -43.6% | |
| AUPH | Aurinia Pharmaceuticals Inc. | $2,013,000 | -45.9% | 162,599 | 0.0% | 0.07% | -40.8% | |
| CCXI | ChemoCentryx, Inc. | $1,960,000 | -31.2% | 78,197 | 0.0% | 0.07% | -25.0% | |
| PRGO | Perrigo Company plcshares | $1,969,000 | -1.2% | 51,224 | 0.0% | 0.07% | +7.8% | |
| ZLAB | Zai Lab Ltd.adr | $1,904,000 | -30.0% | 43,300 | 0.0% | 0.07% | -23.9% | |
| FULC | Fulcrum Therapeutics, Inc. | $1,828,000 | +33.7% | 77,293 | 0.0% | 0.06% | +45.5% | |
| ACAD | ACADIA Pharmaceuticals Inc. | $1,749,000 | +3.7% | 72,225 | 0.0% | 0.06% | +13.0% | |
| MREO | Mereo BioPharma Group plcads | $1,737,000 | -30.0% | 1,551,082 | 0.0% | 0.06% | -23.8% | |
| MEDP | Sell | Medpace Holdings, Inc. | $1,543,000 | -62.4% | 9,435 | -50.0% | 0.05% | -59.1% |
| New | Stevanato Group Societa' Per Azioniordinary shares | $1,432,000 | – | 71,190 | +100.0% | 0.05% | – | |
| MORF | Morphic Holding, Inc. | $1,406,000 | -15.3% | 35,025 | 0.0% | 0.05% | -7.5% | |
| SRRK | Scholar Rock Holding Corp. | $1,403,000 | -48.1% | 108,833 | 0.0% | 0.05% | -43.7% | |
| ITOS | iTeos Therapeutics, Inc. | $1,363,000 | -30.9% | 42,362 | 0.0% | 0.05% | -23.8% | |
| STRO | Sell | Sutro Biopharma, Inc. | $1,347,000 | -72.4% | 163,924 | -50.0% | 0.05% | -70.1% |
| HARP | New | Harpoon Therapeutics, Inc. | $1,292,000 | – | 259,910 | +100.0% | 0.04% | – |
| ACET | Adicet Bio, Inc. | $1,265,000 | +14.2% | 63,329 | 0.0% | 0.04% | +22.2% | |
| FATE | Sell | Fate Therapeutics, Inc. | $1,227,000 | -71.2% | 31,652 | -56.5% | 0.04% | -68.6% |
| ASRT | Assertio Holdings, Inc. | $1,178,000 | +31.6% | 410,575 | 0.0% | 0.04% | +41.4% | |
| Theseus Pharmaceuticals, Inc. | $1,153,000 | -9.1% | 100,000 | 0.0% | 0.04% | -2.4% | ||
| ENDP | Endo International plcshares | $1,143,000 | -38.5% | 494,607 | 0.0% | 0.04% | -33.3% | |
| DHC | Diversified Healthcare Trust | $1,145,000 | +3.6% | 357,720 | 0.0% | 0.04% | +11.1% | |
| ALXO | ALX Oncology Holdings Inc. | $1,119,000 | -21.4% | 66,211 | 0.0% | 0.04% | -15.2% | |
| DSGN | Design Therapeutics, Inc. | $1,055,000 | -24.6% | 65,351 | 0.0% | 0.04% | -17.8% | |
| CYH | Community Health Systems, Inc. | $1,049,000 | -10.8% | 88,335 | 0.0% | 0.04% | -2.6% | |
| SNDX | New | Syndax Pharmaceuticals, Inc. | $982,000 | – | 56,480 | +100.0% | 0.03% | – |
| BEAM | Beam Therapeutics Inc. | $906,000 | -28.1% | 15,817 | 0.0% | 0.03% | -22.0% | |
| ICPT | Intercept Pharmaceuticals, Inc. | $847,000 | -0.1% | 52,067 | 0.0% | 0.03% | +11.1% | |
| RXDX | New | Prometheus Biosciences, Inc. | $835,000 | – | 22,115 | +100.0% | 0.03% | – |
| PRAX | Praxis Precision Medicines, Inc. | $766,000 | -48.2% | 75,000 | 0.0% | 0.03% | -43.8% | |
| DTIL | Precision BioSciences, Inc. | $692,000 | -58.4% | 224,534 | 0.0% | 0.02% | -54.7% | |
| UHT | Universal Health Realty Income Trustshares | $657,000 | -1.9% | 11,258 | 0.0% | 0.02% | +4.5% | |
| CHCT | Community Healthcare Trust Inc. | $629,000 | -10.7% | 14,900 | 0.0% | 0.02% | -4.3% | |
| NHI | National Health Investors, Inc. | $592,000 | +2.6% | 10,038 | 0.0% | 0.02% | +10.5% | |
| EWTX | Edgewise Therapeutics, Inc. | $587,000 | -36.5% | 60,550 | 0.0% | 0.02% | -30.0% | |
| UHS | Sell | Universal Health Services, Inc.class b | $580,000 | -92.5% | 4,000 | -93.3% | 0.02% | -92.0% |
| ARDX | Ardelyx, Inc. | $577,000 | -2.7% | 539,408 | 0.0% | 0.02% | +5.3% | |
| TScan Therapeutics, Inc. | $560,000 | -37.8% | 200,000 | 0.0% | 0.02% | -31.0% | ||
| MOR | MorphoSys AGsponsored ads | $555,000 | -28.0% | 81,867 | 0.0% | 0.02% | -24.0% | |
| RNA | New | Avidity Biosciences, Inc. | $489,000 | – | 26,452 | +100.0% | 0.02% | – |
| BCYC | New | Bicycle Therapeutics PLCsponsored ads | $443,000 | – | 10,086 | +100.0% | 0.02% | – |
| RPTX | Repare Therapeutics Inc. | $415,000 | -32.5% | 29,150 | 0.0% | 0.02% | -25.0% | |
| BDTX | Black Diamond Therapeutics, Inc. | $366,000 | -48.0% | 131,990 | 0.0% | 0.01% | -43.5% | |
| NKTX | Nkarta, Inc. | $330,000 | -25.8% | 28,988 | 0.0% | 0.01% | -14.3% | |
| ONEM | 1Life Healthcare, Inc. | $346,000 | -37.0% | 31,266 | 0.0% | 0.01% | -33.3% | |
| FUSN | Fusion Pharmaceuticals Inc. | $337,000 | +86.2% | 43,394 | 0.0% | 0.01% | +100.0% | |
| New | ZimVie Inc. | $324,000 | – | 14,202 | +100.0% | 0.01% | – | |
| SPPI | Spectrum Pharmaceuticals, Inc. | $148,000 | +1.4% | 114,670 | 0.0% | 0.01% | 0.0% | |
| ABIO | ARCA biopharma, Inc. | $75,000 | +7.1% | 32,461 | 0.0% | 0.00% | +50.0% | |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | $82,000 | -13.7% | 154,310 | 0.0% | 0.00% | 0.0% | |
| VYNE | VYNE Therapeutics Inc. | $88,000 | -36.2% | 135,395 | 0.0% | 0.00% | -25.0% | |
| FVE | AlerisLife Inc. | $52,000 | -26.8% | 24,237 | 0.0% | 0.00% | 0.0% | |
| Bellicum Pharmaceuticals, Inc. | $13,000 | +44.4% | 6,000 | 0.0% | 0.00% | – | ||
| New | NexGel, Inc. | $8,000 | – | 4,243 | +100.0% | 0.00% | – | |
| Exit | Nexgel | $0 | – | -4,243 | -100.0% | 0.00% | – | |
| KALV | Exit | KalVista Pharmaceuticals, Inc. | $0 | – | -31,594 | -100.0% | -0.01% | – |
| IDYA | Exit | IDEAYA Biosciences, Inc. | $0 | – | -20,454 | -100.0% | -0.02% | – |
| KOD | Exit | Kodiak Sciences Inc. | $0 | – | -8,530 | -100.0% | -0.02% | – |
| FMTX | Exit | Forma Therapeutics Holdings, Inc.shares | $0 | – | -53,186 | -100.0% | -0.02% | – |
| Exit | Astellas Pharma Inc. | $0 | – | -88,837 | -100.0% | -0.05% | – | |
| ZGNX | Exit | Zogenix, Inc. | $0 | – | -88,977 | -100.0% | -0.05% | – |
| TBPH | Exit | Theravance Biopharma, Inc. | $0 | – | -656,296 | -100.0% | -0.23% | – |
| MTD | Exit | Mettler-Toledo International Inc. | $0 | – | -6,650 | -100.0% | -0.36% | – |
| ARNA | Exit | Arena Pharmaceuticals, Inc. | $0 | – | -175,976 | -100.0% | -0.53% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Gilead Sciences, Inc. | 41 | Q2 2023 | 12.4% |
| Amgen, Inc. | 41 | Q2 2023 | 5.8% |
| Biogen Inc. | 41 | Q2 2023 | 6.5% |
| Vertex Pharmaceuticals Incorporated | 41 | Q2 2023 | 5.3% |
| Regeneron Pharmaceuticals, Inc. | 41 | Q2 2023 | 9.1% |
| Illumina, Inc. | 41 | Q2 2023 | 3.4% |
| BioMarin Pharmaceutical Inc. | 41 | Q2 2023 | 2.9% |
| Teva Pharmaceutical Industries Ltd. | 41 | Q2 2023 | 3.2% |
| Neurocrine Biosciences, Inc. | 41 | Q2 2023 | 1.4% |
| McKesson Corporation | 41 | Q2 2023 | 2.2% |
View Tekla Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Rallybio Corp | January 23, 2023 | 1,727,067 | 4.6% |
| Zyla Life SciencesSold out | January 29, 2021 | 0 | 0.0% |
| ARCA biopharma, Inc. | January 24, 2020 | 36,068 | 2.3% |
| Verona Pharma plc | February 12, 2019 | 5,296,845 | 4.9% |
| Alliqua BioMedical, Inc. | February 12, 2018 | 165,000 | 3.3% |
| PIERIS PHARMACEUTICALS, INC. | February 12, 2018 | 1,962,380 | 4.4% |
| Intellipharmaceutics International Inc. | February 13, 2015 | 2,184,000 | 9.0% |
| HERON THERAPEUTICS, INC. /DE/ | February 14, 2014 | 20,598,613 | 4.2% |
| MEDWAVE INC | February 14, 2012 | 1,277,372 | 9.8% |
| MZT Holdings, Inc. | February 14, 2012 | 2,553,420 | 4.0% |
View Tekla Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-10 |
| 13F-HR | 2023-02-10 |
| SC 13G/A | 2023-01-23 |
| 13F-HR | 2022-11-01 |
| 13F-HR | 2022-07-29 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
| SC 13G | 2022-01-21 |
| 13F-HR | 2021-11-12 |
View Tekla Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.